A pharmacological master key mechanism that unlocks the selectivity filter gate in K<sup>+</sup> channels.

Schewe, Marcus; Sun, Han; Mert, Ümit; Mackenzie, Alexandra; Pike, Ashley C W; Schulz, Friederike; Constantin, Cristina; Vowinkel, Kirsty S et al. · Science · 2019

basic_science · Level V

Where this comes from

Abstract

Potassium (K<sup>+</sup>) channels have been evolutionarily tuned for activation by diverse biological stimuli, and pharmacological activation is thought to target these specific gating mechanisms. Here we report a class of negatively charged activators (NCAs) that bypass the specific mechanisms but act as master keys to open K<sup>+</sup> channels gated at their selectivity filter (SF), including many two-pore domain K<sup>+</sup> (K<sub>2P</sub>) channels, voltage-gated hERG (human ether-à-go-go-related gene) channels and calcium (Ca<sup>2+</sup>)-activated big-conductance potassium (BK)-type channels. Functional analysis, x-ray crystallography, and molecular dynamics simulations revealed that the NCAs bind to similar sites below the SF, increase pore and SF K<sup>+</sup> occupancy, and open the filter gate. These results uncover an unrecognized polypharmacology among K<sup>+</sup> channel activators and highlight a filter gating machinery that is conserved across different families of K<sup>+</sup> channels with implications for rational drug design.

Medical subject headings